Novo Nordisk A S (NONOF) bonds
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Debt
Borrowings on the balance sheet, Dec 31, 2025
Total debt
142.98B DKK
24.03B DKK due within a year
Net debt
116.51B DKK
After 26.46B DKK of cash
Implied interest rate
5.24%
FY2025 interest ÷ average debt
Interest coverage
18.8×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, DKK
Notes and loans outstanding
Individual notes, bonds and loans
Novo Nordisk A S's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?